Cargando…
Transdermal hormone therapy in postmenopausal women: A review of metabolic effects and drug delivery technologies
Vasomotor symptoms (VMS) associated with menopause can cause significant discomfort and decrease the quality of life for women in the peri-menopausal and post-menopausal stages of life. Hormone therapy (HT) is the mainstay of treatment for menopausal symptoms and is currently the only therapy proven...
Autores principales: | Kopper, Nathan W, Gudeman, Jennifer, Thompson, Daniel J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2761184/ https://www.ncbi.nlm.nih.gov/pubmed/19920906 |
Ejemplares similares
-
Gallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort study
por: Liu, Bette, et al.
Publicado: (2008) -
Effects of transdermal versus oral hormone replacement therapy in postmenopause: a systematic review
por: Goldštajn, Marina Šprem, et al.
Publicado: (2022) -
Effect of Transdermal Estrogen Therapy on Bone Mineral Density in Postmenopausal Korean Women
por: Kim, Hyo Jeong, et al.
Publicado: (2014) -
Recent Advances in Microneedle Platforms for Transdermal Drug Delivery Technologies
por: Mdanda, Sipho, et al.
Publicado: (2021) -
The Effects of Transdermal Estrogen Delivery on Bone Mineral Density in Postmenopausal Women: A Meta-analysis
por: Abdi, Fatemeh, et al.
Publicado: (2017)